Buscar resultados de ensayos clínicos
Marginal Zone Lymphoma - 26 Studies Found
Estado | Estudiar |
Not yet recruiting |
Nombre del estudio: Integrated Molecular and Clinical Profiling to Optimize Outcome Prediction in Splenic Marginal Zone Lymphoma Condición: Splenic Marginal Zone Lymphoma Fecha: 2016-10-23 |
Completed |
Nombre del estudio: Eradication of Helicobacter Pylori in the Management of Stage IE & IIE-1 Primary Low-grade B Cell Lymphoma of MALToma Condición: MALT Lymphoma Fecha: 2005-09-13 Intervenciones: Other: Omeprazole, Amoxicillin, Clarithromycin Omeprazole20 mg,Clarithromycin500 mg b.i.d.,Day 1-14 plus |
Active, not recruiting |
Nombre del estudio: Phase II Study of Chlorambucil and Subcutaneous Rituximab in Patients With Extranodal MALT Lymphoma Condición: MALT Lymphoma Fecha: 2013-03-06 Intervenciones:
|
Completed |
Nombre del estudio: Multicenter Phase II Study to Evaluate the Clinical Activity and the Safety Profile of Everolimus in Marginal Zone B-cell Lymphomas (MZL) Condición: Marginal Zone B-cell Lymphoma Fecha: 2010-07-15 Intervenciones: Drug: Everolimus Everolimus (tablets, 5 mg) is given orally at the dose of 10 mg/day from day 1 to day 2 |
Recruiting |
Nombre del estudio: Prospective Study of Frontline H Pylori Eradication in the Treatment of Early-stage Extragastric MALT Lymphoma Condición: Mucosa-Associated Lymphoid Tissue Lymphoma Fecha: 2016-12-01 |
Terminated |
Nombre del estudio: Safety, Pharmacodynamics, Pharmacokinetics, and Efficacy of GS-9901 in Adults With Relapsed or Refractory Follicular Lymphoma, Marginal Zone Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Lymphoma Condición:
|
Terminated |
Nombre del estudio: 131I-rituximab for Relapsed or Refractory Marginal Zone B-cell Lymphoma Condición: Relapsed or Refractory Marginal Zone B-cell Lymphoma Fecha: 2012-09-04 Intervenciones: Drug: 131I-rituximab |
Completed |
Nombre del estudio: Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter Pylori Condición: Gastric Low-grade MALT Lymphoma With Helicobacter Pylori Positive Fecha: 2010-12-20 Intervenciones: Drug: Rabeprazole Sodium The following 3 drugs are taken o |
Completed |
Nombre del estudio: Velcade in MALT Lymphoma Patients Condición: MALT Lymphoma Fecha: 2006-09-07 Intervenciones: Drug: Bortezomib (Velcade) |
Completed |
Nombre del estudio: Prospective Study of First-line Antibiotic Therapy for Early-stage Gastric MALT Lymphoma for Treatment Outcome Condición: Gastric MALT Lymphoma Fecha: 2006-05-17 Intervenciones: Drug: Omeprazole, Amoxicillin, Clarithromycin |